Article
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
#DermTok: Navigating TikTok’s Acne Advice Misinformation
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Survey Snapshot: Chronic Hand Eczema's Clinical Burden, Treatment Gaps, and Patient Impact Revealed
Evaluating Dupilumab and Upadacitinib for Head and Neck AD